Face to Face
Remidio with RetinaRisk to strengthen AI-driven diabetic retinopathy screening in India...
This partnership brings together two powerful innovations, Remidio’s Medios DR AI for automated DR detection and RetinaRisk’s personalized risk triaging algorithm for progression to sight-threatening DR
Chat with BioVoice
“The integration of genomics into healthcare will revolutionize personalized care ”
Kishore Karumanchi, CEO of aciana shares details on the company’s key offerings, upcoming initiatives, technology trends and future plans
